Three panel discussions discussed future of healthcare, the next breakthrough in pharma and the GCC’s implementation of machine medicine and 3D printing, artificial intelligence and robotics. Panelists expressed their keen interest in the country’s vision and discussed potential markets and areas of interests amongst the pharmaceutical giants. KSA and the U.A.E. continue to be among the major markets for leading industry players and strategies opted by drug makers and healthcare providers.

Forbes Middle East has held its first healthcare event highlighting the current trends and potential opportunities in the healthcare sector, built around a series of panel discussions and keynote speeches by industry leader. Moderated by PwC, conversations centered around shaping the future of healthcare, finding a balance in pharma and implementing machine medicine.
Government representative, His Excellency Amin Al Amiri, Assistant Under Secretary at the Ministry of Health and Dr Ibtesam Al Bastaki, Director of Investment and Partnership, Dubai Health Authority were part of the discussions alongside industry leaders, including: Dr. Azad Moopen, Founder, Chairman and Managing Director of Aster DM Healthcare; Dr Thumbay Moideen, Founder of the Thumbay Group; Mohammed Ali Al Shorafa Al Hammadi, Managing Director and CEO of UEMedical; and Zanubia Shams, Co-Chair for Zulekha Hospitals.
Khuloud Al Omian, Editor-in-Chief of Forbes Middle East, said “GCC healthcare spending is expected to reach $69 billion by 2020. The healthcare ecosystem is currently witnessing a significant transform-ational shift, with technology playing a vital role. It will be a game changer for the sector, with innovation playing an important role. The private sector, together with government authorities will continue to be a key partner in the long-term development of the health industries.”
His Excellency Amin Al Amiri, Assistant Under Secretary at the Ministry of Health highlighted the role of technology and innovation and shared acumen on the country’s growing healthcare expenditure to promote healthcare services.
Dr. Stephen Brookes from The University of Manchester also discussed the future of healthcare, emphasizing the collaboration of public and private partnerships and global initiatives supporting healthcare promotions.
Three panel discussions discussed future of healthcare, the next breakthrough in pharma and the GCC’s implementation of machine medicine and 3D printing, artificial intelligence and robotics. Panelists expressed their keen interest in the country’s vision and discussed potential markets and areas of interests amongst the pharmaceutical giants. KSA and the U.A.E. continue to be among the major markets for leading industry players and strategies opted by drug makers and healthcare providers.
Dr. Azad Moopen- Founder Chairman and Managing Director, at Aster DM Healthcare said, “In alignment with the U.A.E.’s Vision 2021, we continue to focus on fulfilling the need gaps in healthcare delivery and remain committed to making quality affordable healthcare easily accessible to people who need it the most. I believe in the ‘power of now’. We are glad to be at the right place, at the right time and with the right support to turn the vision of world-class healthcare locally available into a reality.”